Trial intelligence / Profile preview

Citalopram plus haloperidol for treatment of delirium in ICU patients

IRCT20191104045328N18Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of citalopram and haloperidol in delirium, sponsored by Arak University of Medical Sciences. Started Oct 2023; status: completed.

02

Drugs

citalopramhaloperidol
03

Conditions

delirium

Beyond the preview

Go deeper on IRCT20191104045328N18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191104045328N18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call